Navigation Links
PCMA Launches New Ad Campaign: 'It's the Oklahoma Drugstore Lobby vs. Oklahoma's Employers'

WASHINGTON, Dec. 4, 2013 /PRNewswire-USNewswire/ -- As the Oklahoma drugstore lobby launches new attacks seeking to undermine tools used by pharmacy benefit managers (PBMs) to lower prescription drug costs, the Pharmaceutical Care Management Association (PCMA) released a new ad campaign today defending the rights of employers to reduce wasteful pharmacy spending.  

The ad notes that, employers think: "It's wrong" for the Oklahoma drugstore lobby "to force Oklahomans to pay more for prescription drugs."

"The agenda promoted by the Oklahoma drugstore lobby would enrich pharmacies by making every other business pay more for prescription drugs," said PCMA President and CEO Mark Merritt.

This special interest legislation (H.B. 2100) could increase prescription drug costs $1.7 billion for the state's employers, seniors, state employee plans, and consumers.

Click here to see the new ad.

"It's the Oklahoma Drugstore Lobby vs. Oklahoma's Employers in the Fight to Reduce Prescription Drug Costs"

The Oklahoma drugstore lobby agenda includes:

  • New employer mandates that raise costs and reduce choices.
  • Giving drugstores new powers to charge consumers more for prescription drugs.
  • Forcing employers to pay more for prescription drugs.

The Federal Trade Commission examined similar Board of Pharmacy legislation and found it would make "collusion easier and increase prescription drug prices if the Pharmacy Board obtains and discloses PBMs competitively sensitive information to pharmaceutical manufacturers, pharmacists, and pharmacies."

A recent report from the National Center for Policy Analysis (NCPA) also confirms that Oklahoma policymakers should avoid enacting laws that undermine employers' ability to use PBM tools.

NCPA is a nonprofit, nonpartisan public policy research organization that develops private, free-market alternatives to government regulation that rely on the strength of the competitive, entrepreneurial private sector.  The NCPA report points out a number of regulations and laws that could increase prescription drug costs, including:

  • Barriers to Competition: State Boards of Pharmacy and Conflicts of Interest
    Background: The report highlights how some states are seeking to transfer regulatory authority of drug plans from the state's insurance commissioner to the state's Board of Pharmacy.

    NCPA: "Because state pharmacy boards are controlled by pharmacists, giving them authority over drug plans creates conflicts of interest that could undermine drug plans' ability to negotiate lower prices with pharmacy networks."

Click here to read the NCPA white paper.

PCMA represents the nation's pharmacy benefit managers (PBMs), which improve affordability and quality of care through the use of electronic prescribing (e-prescribing), generic alternatives, mail-service pharmacies, and other innovative tools for 216 million Americans.

Follow PCMA on Twitter

SOURCE Pharmaceutical Care Management Association
Copyright©2012 PR Newswire.
All rights reserved

Related medicine technology :

1. Carolinas HealthCare System Launches Comprehensive Analytics Capabilities To Improve Health In The Carolinas
2., the cloud-based CRM and internal social network launches free service
3. Finesse Solutions Launches New Website (
4. Seno Medical Instruments Launches Pivotal Study of New Functional Imaging Platform in Breast Cancer Diagnosis
5. Esco Launches Its New Series of Labculture(R) and Labculture(R) Reliant Class II Type A2 Biological Safety Cabinets
6. Bay Alarm Medical Launches New Cellular Medical Alert Option
7. LabCentral Launches Laboratory Operations; Signs American Laboratory Trading as a Gold Sponsor
8. MO BIO Laboratories, Inc. launches new kits for fast DNA and RNA clean-up
9. Ekahau Launches the A4+ RTLS Asset Tag and W4 RTLS Wristband Tag at MEDICA 2013
10. Pharmspective Launches Affordable Care Act eLearning for Healthcare Decision-Makers
11. Levi & Korsinsky, LLP Launches Investigation of SAREPTA THERAPEUTICS, INC. for Possible Violations of Federal Securities Laws
Post Your Comments:
(Date:11/26/2015)... , 26 november 2015 ... kondigt de geplande investering aan van ten ... de laboratoria en het mondiale hoofdkantoor in ... uitbreiding zal resulteren in extra kantoorruimte en ... aan de groeiende behoeften van de farmaceutische ...
(Date:11/26/2015)... , November 26, 2015 ... A new combination approach blends immunotherapy with Bremachlorin-photodynamic therapy ... new combination approach blends immunotherapy with Bremachlorin-photodynamic therapy for ... new combination approach blends immunotherapy with Bremachlorin-photodynamic therapy for ... has found that immunotherapy can be efficiently ...
(Date:11/26/2015)... 26, 2015 ... aanpak combineert immunotherapie met Bremachlorin-photodynamische therapie voor ... ) --> ... ) Uit ... Centrum (LUMC) blijkt ...
Breaking Medicine Technology:
(Date:11/25/2015)... ... November 25, 2015 , ... For the first time, Vitalalert is donating ... Beat ” campaign. The partnership between the two groups began in 2014 with Vitalalert ... cause. , MAP International was founded in 1954 and is an international Christian-based health ...
(Date:11/25/2015)... ... 2015 , ... Dental professionals who would like to become more proficient on ... Dr. Mark Iacobelli’s Advanced Implant Mentoring (AIM) CE course. Courses will be held on ... co-founders of Advanced Implant Mentoring (AIM), Dr. Iacobelli and Dr. D’Orazio are proud to ...
(Date:11/25/2015)... ... 2015 , ... The McHenry County law firm of Botto Gilbert Lancaster, ... Francisco J. Botto and Alex C. Wimmer. Attorneys Botto and Wimmer represented the claimant ... (2d) 130884WC. , According to court documents, Adcock testified that on May 10, 2010 ...
(Date:11/25/2015)... ... November 25, 2015 , ... SCOTTSDALE, ... facial plastic surgeon specializing in both surgical and non-surgical treatments, announced the expansion ... at Hobgood Facial Plastic Surgery. , Highly trained and nationally recognized for ...
(Date:11/25/2015)... ... 25, 2015 , ... In an ongoing Clinical Study conducted by an independent ... UV Angel is evaluating the efficacy of its product and its disinfection protocol. This ... beds) from May 2014 through October 2015 at a 360-bed, acute-care, academic medical center ...
Breaking Medicine News(10 mins):